• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

应用免疫组织化学技术诊断有问题的乳腺病变。

Use of immunohistochemistry in the diagnosis of problematic breast lesions.

机构信息

Department of Histopathology, Nottingham University Hospitals, City Hospital Campus, Nottingham NG5 1PB, UK.

出版信息

J Clin Pathol. 2013 Jun;66(6):471-7. doi: 10.1136/jclinpath-2012-201109. Epub 2013 Mar 13.

DOI:10.1136/jclinpath-2012-201109
PMID:23486609
Abstract

Most diagnoses in breast pathology can be made with H&E sections. Nevertheless immunohistochemistry plays a useful supplementary role. This article reviews the common uses of immunohistochemistry in diagnostic breast pathology. It is important to be aware of the limitations of individual antibodies. Such problems can often be overcome by using panels of antibodies. Quality control is also essential: internal and external controls should show appropriate staining. Immunohistochemistry must be interpreted in combination with the morphology seen on H&E sections. Myoepithelial markers, such as smooth muscle actin, smooth muscle myosin heavy chain and p63, are useful for distinguishing invasive carcinoma from sclerosing lesions and ductal carcinoma in situ (DCIS), and in the classification of papillary lesions. Basal cytokeratins can help distinguish epithelial hyperplasia of usual type (UEH) and clonal proliferations such as DCIS and lobular carcinoma in situ (LCIS). UEH usually shows patchy expression whereas DCIS and other clonal proliferations are typically negative. E-cadherin can usually separate DCIS and LCIS: DCIS typically shows membrane staining and most LCIS is negative. Cytokeratins can be used to detect small nodal metastases or subtle invasive carcinomas such as invasive lobular carcinomas. Immunohistochemistry plays a useful role in diagnosing spindle cell lesions such as a panel of cytokeratins to identify spindle cell carcinomas. Immunohistochemistry is helpful in recognising metastases to the breast. Different antibodies are useful for different tumours: WT1 for ovarian carcinoma; TTF1 for pulmonary adenocarcinoma; S100, melan-A and HMB45 for melanoma; and lymphoid markers for lymphoma.

摘要

大多数乳腺病理学诊断可通过 H&E 切片完成。然而,免疫组织化学起着有用的辅助作用。本文回顾了免疫组织化学在诊断性乳腺病理学中的常见应用。了解单个抗体的局限性很重要。此类问题通常可以通过使用抗体组合来解决。质量控制也至关重要:内部和外部对照应显示适当的染色。免疫组织化学必须与 H&E 切片上的形态学结合进行解释。肌上皮标志物,如平滑肌肌动蛋白、平滑肌肌球蛋白重链和 p63,可用于区分浸润性癌与硬化性病变和导管原位癌 (DCIS),并有助于对乳头状病变进行分类。基底细胞角蛋白有助于区分普通型上皮增生 (UEH) 和克隆性增殖,如 DCIS 和小叶原位癌 (LCIS)。UEH 通常呈斑片状表达,而 DCIS 和其他克隆性增殖通常为阴性。E-钙黏蛋白通常可将 DCIS 和 LCIS 区分开来:DCIS 通常显示膜染色,而大多数 LCIS 为阴性。细胞角蛋白可用于检测小的淋巴结转移或微妙的浸润性癌,如浸润性小叶癌。免疫组织化学在诊断梭形细胞病变(如一组细胞角蛋白以识别梭形细胞癌)中起着有用的作用。免疫组织化学有助于识别乳腺癌转移。不同的抗体对不同的肿瘤有用:WT1 用于卵巢癌;TTF1 用于肺腺癌;S100、黑色素瘤-A 和 HMB45 用于黑色素瘤;以及用于淋巴瘤的淋巴样标志物。

相似文献

1
Use of immunohistochemistry in the diagnosis of problematic breast lesions.应用免疫组织化学技术诊断有问题的乳腺病变。
J Clin Pathol. 2013 Jun;66(6):471-7. doi: 10.1136/jclinpath-2012-201109. Epub 2013 Mar 13.
2
Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.女性乳腺原位癌。一项临床病理、免疫组织化学及DNA倍体研究。
APMIS Suppl. 2003(108):1-67.
3
E-cadherin immunohistochemistry in breast pathology: uses and pitfalls.乳腺病理学中的E-钙黏蛋白免疫组织化学:用途与陷阱
Histopathology. 2016 Jan;68(1):57-69. doi: 10.1111/his.12869.
4
Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications.E-钙黏蛋白在乳腺小叶和导管肿瘤中的差异表达及其生物学和诊断意义。
Am J Clin Pathol. 2001 Jan;115(1):85-98. doi: 10.1309/FDHX-L92R-BATQ-2GE0.
5
[Noninvasive breast carcinomas: anatomicopathological, diagnostic and therapeutic findings].[非侵袭性乳腺癌:解剖病理学、诊断及治疗结果]
Acta Biomed Ateneo Parmense. 1998;69(3-4):113-21.
6
The florid subtype of lobular carcinoma in situ: marker or precursor for invasive lobular carcinoma?叶状原位癌的多形性亚型:浸润性叶状癌的标志物还是前体?
Ann Surg Oncol. 2011 Jul;18(7):1845-51. doi: 10.1245/s10434-011-1563-0. Epub 2011 Feb 2.
7
The role of immunohistochemistry in the differential diagnosis of breast lesions.免疫组织化学在乳腺病变鉴别诊断中的作用。
Pathology. 2009 Jan;41(1):68-76. doi: 10.1080/00313020802563544.
8
[Breast calcifications with percutaneous vacuum-assisted biopsy diagnosis of malignancy or atypical hyerplasia: correlations with surgical findings].经皮真空辅助活检诊断为恶性或非典型增生的乳腺钙化:与手术结果的相关性
Pathologica. 2002 Dec;94(6):299-305. doi: 10.1007/s102420200053.
9
Is there a low-grade precursor pathway in breast cancer?乳腺癌是否存在低度恶性前体途径?
Ann Surg Oncol. 2012 Apr;19(4):1115-21. doi: 10.1245/s10434-011-2053-0. Epub 2011 Sep 21.
10
[Clinicopathologic observation of carcinomas arising in fibroepithelial neoplasms of the breast].[乳腺纤维上皮性肿瘤中癌的临床病理观察]
Zhonghua Bing Li Xue Za Zhi. 2014 Jul;43(7):437-41.

引用本文的文献

1
Malignant Mesenchymal Tumors of the Breast: Current Challenges and New Perspectives on Primary Sarcomas and Malignant Phyllodes Tumors.乳腺恶性间叶肿瘤:原发性肉瘤和恶性叶状肿瘤的当前挑战与新观点
Life (Basel). 2025 Apr 20;15(4):673. doi: 10.3390/life15040673.
2
Primary Undifferentiated Pleomorphic Sarcoma of the Breast: A Case Report with Literature Review of Similar Cases.乳腺原发性未分化多形性肉瘤:1例病例报告并文献复习类似病例
Iran J Pathol. 2024 Winter;19(1):118-125. doi: 10.30699/IJP.2023.2006411.3139. Epub 2023 Dec 29.
3
Pitfalls in breast pathology.
乳腺病理学中的陷阱。
Histopathology. 2023 Jan;82(1):140-161. doi: 10.1111/his.14799.
4
TAp63 and ΔNp63 (p40) in prostate adenocarcinomas: ΔNp63 associates with a basal-like cancer stem cell population but not with metastasis.TAp63 和 ΔNp63(p40) 在前列腺腺癌中的表达:ΔNp63 与基底样癌症干细胞群体相关,但与转移无关。
Virchows Arch. 2021 Apr;478(4):627-636. doi: 10.1007/s00428-020-02944-z. Epub 2020 Oct 10.
5
∆Np63/p40 correlates with the location and phenotype of basal/mesenchymal cancer stem-like cells in human ER and HER2 breast cancers.∆Np63/p40与人类雌激素受体(ER)和人表皮生长因子受体2(HER2)阳性乳腺癌中基底/间充质样癌症干细胞的位置和表型相关。
J Pathol Clin Res. 2020 Jan;6(1):83-93. doi: 10.1002/cjp2.149. Epub 2019 Dec 6.
6
Multiplexed imaging reveals heterogeneity of PI3K/MAPK network signaling in breast lesions of known PIK3CA genotype.多重成像揭示了已知PIK3CA基因型的乳腺病变中PI3K/MAPK网络信号的异质性。
Breast Cancer Res Treat. 2016 Oct;159(3):575-83. doi: 10.1007/s10549-016-3962-1. Epub 2016 Aug 31.
7
Breast carcinoma metastasis to the lacrimal gland: Two case reports.乳腺癌转移至泪腺:两例报告。
Oncol Lett. 2015 Aug;10(2):1031-1035. doi: 10.3892/ol.2015.3282. Epub 2015 May 27.
8
Immunostaining of ∆Np63 (using the p40 antibody) is equal to that of p63 and CK5/6 in high-grade ductal carcinoma in situ of the breast.在乳腺高级别导管原位癌中,∆Np63(使用p40抗体)的免疫染色与p63和CK5/6的免疫染色相同。
Virchows Arch. 2015 Jul;467(1):67-70. doi: 10.1007/s00428-015-1766-z. Epub 2015 Apr 8.
9
Lobular carcinoma of the breast with gastrointestinal metastasis.伴有胃肠道转移的乳腺小叶癌。
Proc (Bayl Univ Med Cent). 2015 Jan;28(1):50-3. doi: 10.1080/08998280.2015.11929185.
10
Primary malignant melanoma of the breast: A case report and review of the literature.原发性乳腺恶性黑色素瘤:一例病例报告及文献复习
Oncol Lett. 2014 Jul;8(1):238-240. doi: 10.3892/ol.2014.2120. Epub 2014 May 7.